Immusoft

Developer of novel therapies designed for the treatment of rare diseases. The company develops autologous cell therapies based on its immune system programming technology that entails collecting a type of the patient's immune cells, called B cells which can turn into biofactories each of which manufactures and secretes various antibodies, enabling the medical community to combat infectious diseases.

Founders Fund

🏥 Healthcare